title: [Hormone replacement therapy in France 5 years after the decrease in use].
abstract: Following the publication of the WHI randomized trial in 2002, a drastic decrease in Hormone Replacement Therapy (HRT) was observed due to an incredible publicity of the results of this trial and new recommendations from the drug agencies. The consequences of these rapid and important prescriptions of HRT are still not fully evaluated. A decrease in breast cancer incidence was however reported and discussed through over western countries. We present herein the actual types of HRT treatment used in France and report our interpretation of the decrease of breast cancer incidence.
authors.affiliation: Unité de gynécologie endocrinienne, Hôtel-Dieu de Paris Université Paris-Descartes, 75181 Paris Cedex 4. anne.gompel@htd.aphp.fr
authors.forename: Anne
authors.initials: A
authors.lastname: Gompel
mesh_terms: D001943:Breast Neoplasms / Q000453:epidemiology; D002318:Cardiovascular Diseases / Q000453:epidemiology; D011307:Drug Prescriptions / Q000706:statistics & numerical data; D005260:Female; D005602:France / Q000453:epidemiology; D020249:Hormone Replacement Therapy / Q000706:statistics & numerical data* / Q000639:trends; D006801:Humans